ClinicalTrials.Veeva

Menu

the Effect of Exercise and Oral Supplement Intervention in Sarcopenia Markers in Hemodialysis Patients

C

China Medical University

Status

Invitation-only

Conditions

Sarcopenia

Treatments

Dietary Supplement: Nutrition intervention
Other: 3 hours combined intervention ( Exercise and nutrition)
Other: 1 hour combined intervention ( Exercise and nutrition)

Study type

Interventional

Funder types

Other

Identifiers

NCT05809219
NSTC 112-2320-B-039-008

Details and patient eligibility

About

Objective: To assess the effect of different post-exercise oral nutritional supplement intake timing on sarcopenia indicators in hemodialysis patients.

Study Design: 24-weeks Randomized Control Trial (RCT), includes 12-wk intervention period and 12-week follow up period.

Setting & Participants: Maintenance hemodialysis patients who were older than 20 years old meet sarcopenia diagnosis criteria.

Intervention: Group A: During intervention period, participants have 3 times exercise program per week. Each program is 30 minutes of resistance exercise and aerobic exercise. Participants take oral supplement in 1 to 2 hours after exercise program. Group B: Participants have the same exercise program and oral supplement as Group A. However, they take oral supplement in 2.5-4 hours after exercise program. Group C: Participants only take oral supplement. Control group: Participants maintain usual diet and physical activity without any intervention.

Enrollment

200 estimated patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Hemodialysis treatment longer than 3 months
  • Hemodialysis treatment 3 times treatment per weeks
  • Kt/V≥1.2 or URR≥65%
  • Taking foods by oral
  • Meeting the criteria of sarcopenia.

Exclusion criteria

  • Soy allergy
  • Amputation
  • Significantly edema
  • Receiving palliative care
  • Severe angina
  • Unstable arrhythmias
  • Severe infection
  • Heart failure (class 4 of New York Heart Association scale)
  • Central venous catheter or femoral arteriovenous fistula
  • Pacemaker
  • Pregnancy
  • Severe paleness
  • Severe difficulty breathing
  • Chest pain
  • Hospitalization 3 months before recruited in this study
  • Oral supplement intolerance diagnosed by the doctor or dietitian
  • Bone injury/nerve damage/cognition impairment affecting physical activity intervention

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

200 participants in 4 patient groups

Control group
No Intervention group
Description:
Participants maintain usual diet and physical activity without any intervention
1 hour combined intervention ( Exercise and nutrition)
Experimental group
Description:
During intervention period, participants have 3 times exercise program per week. Each program is 30 minutes of resistance exercise and aerobic exercise. Participants take oral supplement (103 kcal and 8.4 g of protein) in 1 to 2 hours after exercise program.
Treatment:
Other: 1 hour combined intervention ( Exercise and nutrition)
3 hours combined intervention ( Exercise and nutrition)
Experimental group
Description:
The only one different between "1 hour combined intervention" and this intervention is the time interval between exercise and nutrition. The time interval of "1 hour combined intervention" is 1 to 2 hour, and this intervention is 2.5-4 hours. Other procedure is totally the same.
Treatment:
Other: 3 hours combined intervention ( Exercise and nutrition)
Nutrition intervention
Experimental group
Description:
Participants only take oral supplement. The oral supplement is the same as the "1 hour combined intervention" and "3 hours combined intervention".
Treatment:
Dietary Supplement: Nutrition intervention

Trial contacts and locations

1

Loading...

Central trial contact

PEIYU WU

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems